Free Trial
→ Crypto Genius: 12,000% in 12 months? [Here’s how] (From Paradigm Press) (Ad) Buy AEON Stock  Free AEON Stock Alerts

AEON Biopharma (AEON) SEC Filings & 10K Form

AEON Biopharma logo
$0.53 -0.01 (-1.74%)
Closing price 04:00 PM Eastern
Extended Trading
$0.53 -0.01 (-1.03%)
As of 07:44 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent AEON Biopharma SEC Filings

Export to Excel
DateFilerForm TypeView
03/10/2025
7:45 AM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Alta Partners LLC (Filed by)
Form SCHEDULE 13G
03/10/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/03/2025
12:51 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Dauntless Investment Group, LLC (Filed by)
Form SCHEDULE 13G
02/24/2025
1:01 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
3:44 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Polar Asset Management Partners Inc. (Filed by)
Form SCHEDULE 13G/A
02/07/2025
3:07 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/23/2025
3:45 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEF 14A
01/22/2025
3:02 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
PALMISANO ROBERT J (Filed by)
Form SCHEDULE 13D
01/13/2025
3:08 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
L1 Capital Global Opportunities Master Fund, Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
3:14 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
S.H.N. Financial Investments Ltd. (Filed by)
Form SCHEDULE 13G
01/13/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form PRE 14A
01/08/2025
3:15 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
BIGGER CAPITAL FUND L P (Filed by)
Form SCHEDULE 13G
01/07/2025
3:05 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/07/2025
5:04 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
01/06/2025
8:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
5:00 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B5
11/13/2024
3:06 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:07 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
3:08 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
10/07/2024
4:01 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/10/2024
8:04 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4/A
09/04/2024
8:52 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Carter Eric G (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:53 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Oh Chad (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
FISCHER JOST (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:58 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Wilson Alexander Blair (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:59 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Forth Marc (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:49 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
PALMISANO ROBERT J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
8:51 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Thunen Shelley B (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2024
11:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
08/12/2024
3:20 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 424B3
08/12/2024
3:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
08/05/2024
11:15 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form EFFECT
07/29/2024
3:11 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
Grodnensky Oleg (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/23/2024
3:43 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form S-1/A
07/09/2024
7:06 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/24/2024
7:02 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Sy Jennifer (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/16/2024
3:27 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:09 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/14/2024
3:07 PM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
8:05 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 10-K/A
America’s Retirement Accounts Are at Risk—Here’s Why (Ad)

When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. Now… as new tariffs take effect, gold is breaking records again. You've hopefully already seen this in action… but gold is surpassing $3,000 per ounce for the first time EVER.

Go Here to Learn What's Happening and How to Prepare >>
05/14/2024
8:14 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form DEFA14A
05/14/2024
8:15 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form ARS/A
05/03/2024
6:01 AM		AEON Biopharma, Inc. (Filer)
AEON Biopharma, Inc. (Filer)
AEON Biopharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2024
3:18 PM		AEON Biopharma, Inc. (Subject)
AEON Biopharma, Inc. (Subject)
AEON Biopharma (Subject)
NYSE AMERICAN LLC (Filed by)
Form 25-NSE
04/18/2024
5:22 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Park Seongsoo (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/16/2024
8:09 PM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
Form 4/A
04/12/2024
6:00 AM		AEON Biopharma, Inc. (Issuer)
AEON Biopharma, Inc. (Issuer)
AEON Biopharma (Issuer)
Daewoong Co., Ltd (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:AEON) was last updated on 4/3/2025 by MarketBeat.com Staff
From Our Partners
“Fed Proof” Your Bank Account with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...
Porter & Company | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Musk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...
InvestorPlace | Sponsored
It’s Time to Buy Elon’s “ChatGPT Killer”
Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....
Brownstone Research | Sponsored
Retirement Nightmare? It’s Already Happening.
The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...
Investors Alley | Sponsored
Why Elon Musk Is Investigating Fort Knox
With gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...
The Oxford Club | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored